KIORA PHARMACEUTICALS INC
Clinical-stage company developing advanced therapies for retinal diseases.
KPRX | US
Overview
Corporate Details
- ISIN(s):
- US49721T3095
- LEI:
- Country:
- United States of America
- Address:
- 169 SAXONY RD., 92024 ENCINITAS
- Website:
- https://kiorapharma.com/
- Sector:
- Manufacturing
Description
Kiora Pharmaceuticals, Inc. is a clinical-stage company focused on developing advanced therapies for retinal diseases. The company's strategy is to target critical pathways underlying vision-threatening conditions using innovative small molecules. Its primary objective is to develop treatments that can slow, stop, or restore vision loss, with a particular focus on ophthalmic conditions that have limited or no effective therapies currently available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all KIORA PHARMACEUTICALS INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for KIORA PHARMACEUTICALS INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for KIORA PHARMACEUTICALS INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
